Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2569 |
Chlorotrianisene
tris(p-methoxyphenyl)chloroethylene,氯丁烯二烯,CTA,tri-p-anisylchloroethylene,氯烯雌醚,TACE |
Estrogen Receptor/ERR; Estrogen/progestogen Receptor; COX | Endocrinology/Hormones; Immunology/Inflammation; Neuroscience |
Chlorotrianisene (tri-p-anisylchloroethylene) 是长效、可口服、亲脂性高的合成三苯乙烯 (TPE) 衍生物和选择性雌激素受体调节剂,有雌激素活性,也有抗雌激素活性。它还有效抑制COX-1并抑制全血中的血小板聚集。 | |||
T8961 |
GW280264X
Carbamic acid |
MMP | Proteases/Proteasome |
GW280264X (Carbamic acid) 是一种 ADAM10/TACE (ADAM17)金属蛋白酶抑制剂。它有效阻断 TACE (ADAM17)和 ADAM10的 IC50分别为 8.0 nM 和 11.5 nM。其中ADAM10/17 能够调节胶质母细胞瘤起始细胞的免疫原性。 | |||
T0914 |
Metacetamol
酰胺苯酚,3-Acetamidophenol |
Others | Others |
Metacetamol (3-Acetamidophenol) 是对乙酰氨基酚的衍生物,为其无毒区域异构体,是一种非处方镇痛剂和解热剂,也可用作有机合成中间体。 | |||
T1888 |
Tacedinaline
Acetyldinaline,N-acetyldinaline,PD-123654,CI994,Goe-5549 |
Apoptosis; HDAC | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair |
Tacedinaline (CI994) 是一种组蛋白脱乙酰酶抑制剂,抑制重组 HDAC 1, 2 和 3 的IC50值分别为 0.9,0.9,1.2 μM。 | |||
TP1413L |
Crustacean Cardioactive Peptide Acetate
CCAP acetate |
||
Crustacean Cardioactive Peptide Acetate (CCAP acetate) 是 是节肢动物中最保守和普遍存在的神经肽,在昆虫中由腹侧神经索中的保守神经元网络产生。Crustacean Cardioactive Peptide Acetate 是一种环酰胺化九肽激素,常见于昆虫,甲壳类动物和其他节肢动物中。 | |||
T10218 |
Abatacept
CTLA4lg |
Others | Others |
Abatacept (CTLA4lg) is a soluble fusion protein consisting of the extracellular domain of human CTLA4 and a fragment of the Fc portion of human IgG1 (hinge and CH2 and 3 domains). It is a selective T-cell co-stimulation modulator and a protein drug for au | |||
TP1413 |
Crustacean Cardioactive Peptide (CCAP)
Crustacean Cardioactive Peptide CCAP,甲壳类心脏活性肽 |
||
Crustacean cardioactive peptide (CCAP) is a highly conserved, amidated cyclic nonapeptide with the primary structure PFCNAFTGC-NH2 (ProPheCysAsnAlaPheTyrGlyCys-NH2) and a disulfide bridge between Cys3 and Cys9. It is found in crustaceans and insects where | |||
T64239 | Belatacept | ||
Belatacept (BMS 224818) 是一种选择性的 T 细胞共刺激 (T-cell costimulation) 阻滞剂。Belatacept 能够结合 CD 80/86 配体,从而对 CD-28 介导的 T 细胞共刺激表现出抑制作用。Belatacept 能够用于研究器官移植免疫抑制。 | |||
T24705 |
Ramentaceone
NSC-208733,NSC 624625,NSC 208733,NSC208733,NSC-624625 |
||
Ramentaceone is an antineoplastic. | |||
T82666 |
Crustacean cardioactive peptide
CCAP |
||
CCAP(Crustacean cardioactive peptide)为一种具有调节昆虫心脏功能的非极性肽,由9个氨基酸组成,最初自tobacco hawkmoth(Manduca sexta)中分离。其结构特征包括第3位与第9位氨基酸的半胱氨酸残基形成的二硫键,以及羧基末端的氨化。 | |||
T4368 |
Miriplatin
米铂,SM-11355 |
DNA Alkylator/Crosslinker | DNA Damage/DNA Repair |
Miriplatin (SM-11355) 是一种烷化剂,是一种用于 TACE 的铂络合物,有望用于治疗肝细胞癌。 | |||
T30531L |
BMS-561392 Formic acid
BMS-561392 Formic acid(611227-74-8 Free base) |
MMP | Proteases/Proteasome |
BMS-561392 Formic acid 是 TACE 的选择性抑制剂,可降低 TNFalpha 水平。 | |||
T21297 |
Miriplatin hydrate
SM-11355 (hydrate),Miripla,Miriplatin,SM 11355,SM11355,SM-11355,Miriplatin hydrate |
DNA Alkylation | DNA Damage/DNA Repair |
Miriplatin hydrate (SM-11355 (hydrate)) (MPT)是一种用于TACE 的新型铂类化合物,在肝细胞癌(HCC)的治疗中显示出良好的前景。米铂是一种亲脂性铂复合物,容易悬浮在碘油中,并在肿瘤组织中逐渐释放活性铂化合物。 | |||
T7522 |
GI254023X
GI 254023X |
MMP; Immunology/Inflammation related | Immunology/Inflammation; Proteases/Proteasome |
GI254023X 是MMP9和ADAM10抑制剂,它们的IC50s 分别为 2.5 和 5.3 nM。 | |||
T27592 |
IK-862
IK 862 |
||
IK-862 is a selective inhibitor of TACE (ADAM17). | |||
T70664 |
TAPI-0
|
||
TAPI-0 is a matrix metalloprotease (MMP) and TACE inhibitor. | |||
T27507 |
GW-3333
GW 3333,GW3333 |
||
GW-3333 is an matrix metalloproteinase inhibitor. It is also a tumor necrosis factor-alpha (TNF)-Converting Enzyme (TACE) inhibitor. The efficacy of GW3333 suggests that dual inhibitors of matrix metalloproteinases and TACE may prove therapeutic as antiar | |||
T69181 |
BMS-566394
|
||
BMS-566394 is a potent, exceptionally selective inhibitor of TNF-α converting enzyme (TACE). | |||
T6009 |
TAPI1
TAPI 1,TAPI,TAPI-1 |
MMP | Proteases/Proteasome |
TAPI1 (TAPI) 是一种 ADAM17/TACE 抑制剂,可抑制细胞因子受体的脱落。 | |||
T4122 |
TAPI-1 trifluoroacetate (163847-77-6(free base))
|
MMP | Proteases/Proteasome |
TAPI-1 trifluoroacetate 是一种 ADAM17/TACE 抑制剂,可阻断细胞因子受体的脱落。 | |||
TQ0129 |
TNF Protease Inhibitor 2
TAPI-2 |
MMP | Proteases/Proteasome |
TAPI-2 is a broad-spectrum inhibitor of MMP (IC50: 20 μM), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM). | |||
TP2107 |
TAPI 0
|
||
ADAM-17 (TACE) and MMP inhibitor; attenuates TNF-α processing. Acts in concert with GM6001 to inhibit Chlamydia trachomatis growth. | |||
T41179 |
CL 82198 hydrochloride
|
||
CL 82198 hydrochloride is a selective inhibitor of MMP-13 (89% inhibition at 10μg/mL) that displays no activity at MMP-1, MMP-9 or TACE. Inhibitsin vitroinvasion by the human pituitary adenoma cell line HP75. Rescues paclitaxel induced axon degradation and reduces associated neurotoxicity in zebrafish. | |||
T14312 |
Apratastat
|
MMP; TNF | Apoptosis; Proteases/Proteasome |
Apratastat is an orally active, potent, and reversible dual inhibitor of tumor necrosis factor-α converting enzyme (TACE) and matrix metalloproteinases (MMPs) and it also can potently inhibit the release of TNF-α in vitro, ex vivo, and in vivo with IC50s of 144 ng/mL in vitro and 81.7 ng/mL ex vivo, respectively[1]. | |||
T63390 |
(S,S)-TAPI-1
|
||
(S,S)-TAPI-1 是一种 TAPI-1 的异构体。其中 TAPI-1是金属蛋白酶 (MMP) 抑制剂,也是 TACE(ADAM17) 抑制剂,对多种细胞表面蛋白脱落表现出有效的抑制作用。 | |||
TP2108 |
TAPI 2
|
||
ADAM-17 (TACE) and MMP inhibitor (Ki = 120 nM at ADAM-17). Sensitizes cancer stem cells to the lethal effects of 5-FU in vitro. Blocks shedding of TNF-α from cell membranes. | |||
T28985 |
TMI-1
WAY-171318 |
Apoptosis; MMP | Apoptosis; Proteases/Proteasome |
TMI-1 (WAY-171318) 是一种有效的抑制剂,用于抑制去整合素金属酶17 (ADAM17) 和其他基质金属蛋白酶MMPs。TMI-1 能够有效地抑制LPS 诱导的人原代单核细胞和人全血中TNF-α的分泌。TMI-1 在三阴性 (TN) 和过度表达ERBB2的乳腺肿瘤细胞系中选择性地诱导Caspase 依赖的细胞凋亡。 | |||
T37726 |
MMP-9 Inhibitor I
|
||
MMP-9 inhibitor I is an inhibitor of matrix metalloproteinase-9 (MMP-9) that is selective over MMP-1 and MMP-13 (IC50s = 5, 1,050, and 113 nM, respectively). It also decreases the activity of TNF-α converting enzyme (TACE) in a dose-dependent manner (IC50 = 0.54 μM). MMP-9 inhibitor I decreases TNF-α secretion stimulated by LPS in BV-2 microglial cells when used at concentrations of 50 and 100 μM. | |||
T41079 |
MMP13-IN-2
MMP13-IN-2 |
||
MMP13-IN-2 is a highly potent, selective, and orally active inhibitor of MMP-13. It demonstrates exceptional potency against MMP-13, with an IC50 value of 0.036 nM, and exhibits selectivities greater than 1,500-fold over MMP-1, 3, 7, 8, 9, 14, and TACE. Moreover, MMP13-IN-2 possesses the capability to effectively inhibit collagen release from cartilage in vitro. Consequently, MMP13-IN-2 holds great potential for advancing research on collagenase-related diseases. |